Yesterday UNPA held a conference call with Cara Welch, Acting Special Assistant to the Deputy Commissioner for Policy, Planning, Legislation, and Analysis, to discuss the upcoming FDA public meeting which will address "responsible innovation in dietary supplements" (May 16, 2019). The full announcement can be seen here.
Here is a summary of our call with Cara:
Within the NDI discussion, UNPA has been invited to present views with respect to synthetic botanicals, an ever-hot topic. I will present for UNPA. FDA also invited UNPA to present comments during the final public session. Larisa Pavlick will speak for UNPA and place our comments into the public record.
FDA stressed what this public meeting is not about. It is not about CBD. That will be a different day. It's not about "amendments to DSHEA" (or "DSHEA 2.0" as we refer to it internally). It is not intended to discuss the topic of mandatory product registration or other issues that have been floated within industry press or at various trade association meetings.
In short, we are advised this meeting is intended to continue from prior public meetings to more fully explore issues around the definition of dietary ingredient, use of DIs in the food supply, and various issues surrounding new dietary ingredients.
Of course, we are pleased to be invited by FDA to participate. We will seek your input as we develop our presentation on synthetic botanicals. This represents the official beginning of UNPA's DSHEA 2.0 working group. Please look for an invitation to join this working group to participate in the full range of issues that will include: